Whole body aluminium in chronic renal failure and dialysis encephalopathy.
Whole body calcium, phosphorus and nitrogen have been measured by in vivo neutron activation analysis in patients with chronic renal failure, including 9 with dialysis encephalopathy. Aluminium was also activated by this procedure, but to the same radioactive product as that from phosphorus: its presence was therefore detected as an increase in the apparent total body phosphorus above that expected for a person with the same calcium content. Patients with dialysis encephalopathy had slightly more apparent phosphorus than others with chronic renal failure, although the difference was not statistically significant. This difference corresponded to an excess of aluminium not greater than 3.3 g(95% confidence limit) which places an upper limit on excess aluminium accumulation in this condition.
D000328:Adult; D000535:Aluminum / Q000302:isolation & purification*; D001927:Brain Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D010758:Phosphorus / Q000302:isolation & purification; D006435:Renal Dialysis / Q000009:adverse effects; D014915:Whole-Body Counting
D010758:Phosphorus; D000535:Aluminum